TheraGauze™ Diabetic Foot Ulcer Study Receives 1st Place

(Newport News, Virginia) – Soluble Systems, LLC, today announced that a presentation of its clinical study on the treatment of Diabetic Foot Ulcers using TheraGauze™ with and without Regranex®, was awarded first place for the "Outstanding Poster Abstract" at the American Podiatric Medical Association Annual Scientific Meeting held July 23 to 26, 2008.

The award-winning abstract "A Randomized, Multi-Center, Prospective Analysis of Diabetic Foot Ulcers Treated with TheraGauze + Regranex™ and TheraGauze™ alone, a Moisturecontrolling Smart Dressing" was presented by Adam Landsman, DPM, PhD, Beth Israel Medical Center, Harvard School of Medicine, Boston, Massachusetts. Dr. Landsman was a coinvestigator for the TheraGauze™ clinical study.

Dr. Landsman commented, "I am honored and pleased to receive such a distinguished award from my colleagues at the APMA. I congratulate Soluble Systems for developing this new class of Smart dressings (Skin Moisture Rebalancing Technology (SMRT) that differentially regulate moisture across the wound interface. TheraGauze™ is my product of choice for the most complex wounds, but works great when just a little moisture control is needed as well. The data from the study indicates that precise moisture control is critical to wound healing and can significantly accelerate the rate of closure and increase the percentage of wounds that close."

"We are extremely pleased that this presentation by Dr. Landsman should receive such a prestigious award at the annual meeting of the country's leading organization of podiatric medical professionals," stated Chief Executive Officer T. Kerry McCarter. "This is further evidence that the medical community is recognizing the merits of TheraGauze’s SMRT (Skin Moisture Rebalancing Technology) capable of precisely regulating moisture at the cellular level across the wound site. This clinical trial supports TheraGauze™ as the better and safe alternative to Regranex® for treatment of diabetic foot ulcers. Soluble Systems, LLC thanks Dr. Landsman for his pioneering research and is honored to work with such a respected researcher and institution.”

The APMA Annual Meeting was attended by approximately 3,000 medical lower extremity specialists who witnessed hundreds of presentations and speeches in the course of the four-day Annual Scientific Meeting.

ABOUT THE AMERICAN PODIATRIC MEDICAL ASSOCIATION

The American Podiatric Medical Association is the premier professional organization representing the nation's Doctors of Podiatric Medicine. The APMA represents approximately 80 percent of the podiatrists in the country. Within APMA's umbrella of organizations are 53 component societies in states and other jurisdictions, as well as 21 affiliated and related societies.

APMA's Council on Podiatric Medical Education is the body designated by the U.S. Department of Education to accredit the nation's podiatric medical schools. In addition, the Council has the responsibility to approve residency programs and continuing medical education programs. The Council recognizes certifying boards within podiatric medicine which meet its standards.

ABOUT THERAGAUZE™

TheraGauze™ is a sterile polymer wound care dressing that regulates moisture differentially across the wound site. This precise moisture regulation is achieved by the proprietary Skin Moisture Rebalancing Technology (SMRT) found in TheraGauze™. Inert, breathable polymer chains are engineered to form a vertical matrix surrounded by microscopic fractalized channels. This biomimetic nanostructure enables TheraGauze™ to regulate moisture as needed at the cellular level.

TheraGauze™ is currently available in two sizes: 2x2 inches and 4.125x4.125 inches. Ordering and additional information can be found at www.solublesystems.com.

*Regranex® is a registered trademark of Ortho-McNeil Pharmaceutical, Inc.